Navigation Links
Hologic Announces Expiration of 6.25% Senior Notes Exchange Offer
Date:3/22/2013

BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the expiration of its offer to exchange (the Exchange Offer) up to $1 billion aggregate principal amount of its 6.25% Senior Notes due 2020 which have been registered under the Securities Act of 1933, as amended (the Exchange Notes), for up to $1 billion of the Company's outstanding 6.25% Senior Notes due 2020, which were issued on August 1, 2012 in a private placement (the Old Notes). The Exchange Notes have substantially identical terms to the Old Notes. The Exchange Offer expired at 5:00 p.m. Eastern Time, on March 22, 2013.

Wells Fargo Bank, National Association, the exchange agent for the Exchange Offer, has advised that Old Notes in the aggregate principal amount of $994,130,000, representing 99.41% of the aggregate principal amount, were validly tendered and not validly withdrawn prior to the expiration of the Exchange Offer. The Company has accepted for exchange all of the validly tendered Old Notes, and expects to issue the Exchange Notes on or about March 27, 2013.

This press release is for informational purposes only and is neither an offer to exchange, nor a solicitation of an offer to sell, the Exchange Notes. The Exchange Offer was made pursuant to the prospectus dated February 21, 2013.

About Hologic, Inc. Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.Contacts:Deborah GordonDavid CrossVice President, Investor RelationsVice President & Treasurer(781) 999-77(781) 999-7789deborah.gordon@hologic.comdavid.cross@hologic.com Al Kildani Senior Director, Investor Relations(858) 410-8653  al.kildani@hologic.com  

 


'/>"/>
SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic Completes Sale of LIFECODES to Immucor
2. Hologic Announces Completion of Loan Repricing
3. Hologics 3D Mammography Technology to be the "New Standard of Care," According to Healthcare Research Firm KLAS
4. Hologic to Showcase Game-Changing Breast Tomosynthesis Technology and Other Product Innovations at the European Congress of Radiology in Vienna
5. Hologic Announces First Quarter Fiscal 2013 Operating Results
6. Hologic to Showcase 3D Mammography and Other Recent Innovations in Healthcare at the 38th Arab Health Congress in Dubai
7. HOLOGIC ANNOUNCES ORGANIZATIONAL CHANGES TO ITS DIAGNOSTICS SEGMENT; INTEGRATION OF GEN-PROBE PROCEEDING AHEAD OF SCHEDULE
8. Hologic to Showcase Award Winning 3D Mammography and Other Advanced Imaging Technologies at RSNA 2012
9. Hologic Announces Fourth Quarter and Fiscal 2012 Operating Results
10. Hologic to Showcase Advancement Simplifying Removal of Large Intrauterine Pathology at AAGL
11. Hologic, Inc. Marks Breast Cancer Awareness Month by Ringing the Opening Bell at NASDAQ and Taking 3D Mammography on the Road
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
Breaking Medicine Technology:
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
Breaking Medicine News(10 mins):